The preset invention relates to a biomarker for identifying {HEAD ~ the subgroup} of {TAIL ~ early stage lung adenocarcinoma patients} in early stage non small cell lung cancer , which is T lymphokine activated killer cell originated protein kinase , and a therapeutic target for lung cancer 
of
The preset invention relates to a biomarker for identifying { HEAD ~ the subgroup } of { TAIL ~ early stage lung adenocarcinoma patients } in early stage non small cell lung cancer , which is T lymphokine activated killer cell originated protein kinase , and a therapeutic target for lung cancer
OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD REL TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH